Immunosuppression with monoclonal antibodies and CTLA4-Ig after myoblast transplantation in mice

Transplantation

Volumn 62, Issue 7, 1996, Pages 962-967

  Guérette, Benoît ^a   Gingras, Marc ^a   Wood, Kathryn ^b   Roy, Raynald ^a   Tremblay, Jacques P ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CD4 ANTIGEN; CD8 ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; MYOBLAST; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; BETA-GALACTOSIDASE; CELL TRANSPLANTATION; FEMALE; FLOW CYTOMETRY; GENES, REPORTER; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MUSCLES;

EID: 0029802352     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199610150-00015     Document Type: Article

References (31)

1. Ray PN, Belfall B, Duff C, et al. Cloning of the breakpoint of an Xp21 translocation associated with Duchenne muscular dystrophy. Nature 1985; 318: 672.
2. Monaco AP, Nerve RL, Colleti-Feener C, Bertelson CJ, Kurnit DM, Kunkel LM. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 1986; 323: 646.
3. Hoffman EP, Kunkel LM, Brown RH. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51: 919.
4. Bulfield B, Siller WG, Wight PAL, Moore KJ. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 1984; 81: 1189.
5. Sicinski P, Rider-Cook AS, Geng Y, Barnard EG, Darlison M, Barnard P. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 1989; 244: 1578.
6. Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 1989; 337: 176.
7. Morgan JE, Hoffman EP, Partridge TA. Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse. J Cell Biol 1990; 111: 2437.
8. Huard J, Verreault S, Roy R, Tremblay JP, Tremblay M. High efficacy of muscle regeneration after human myoblast clone transplantation in SCID mice. J Clin Invest 1994; 93: 586.
9. Law PK, Bertorini TE, Goodwin TG, et al. Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy. Lancet 1990; 336: 114.
10. Tremblay JP, Malouin F, Roy R, et al. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transpl 1993; 2: 99.
11. Gussoni E, Pavlath GK, Lanctot AM, et al. Normal dystrophin transcripts detected in DMD patients after myoblast transplantation. Nature 1992; 356: 435.
12. Mendell JR, Kissel JT, Amato AA, et al. Myoblast transfer in the treatment of Duchenne muscular dystrophy. N Engl J Med 1995; 333: 832.
13. Guérette B, Roy R, Tremblay M, Asselin I, Kinoshita I, Tremblay JP. Increased granzyme B mRNA following alloincompatible myoblast transplantation. Transplantation 1995; 9: 1011.
14. Guérette B, Asselin I, Vilquin JT, Roy R, Tremblay JP. Lymphocyte infiltration following allo- and xenoblast transplantation in mdx mice. Muscle Nerve 1995; 18: 39.
15. Kinoshita I, Vilquin, JT, Guérette B, Asselin I, Roy R, Tremblay JP. Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve 1994; 17: 1407.
16. Kinoshita I, Vilquin JT, Gravel C, Roy R, Tremblay JP. Myoblast allotransplantation in primates. Muscle Nerve 1995; 18: 1217.
17. Pearson CT, Madsen JC, Larsen CP, Morris PJ, Wood KJ. Induction of transplantation tolerance in adults using donor antigen an anti-CD4 monoclonal antibody. Transplantation 1992; 54: 475.
18. Pearson CT, Darby CR, Bushell AR, West LJ, Morris PJ, Wood KJ. The assessment of transplantation tolerance induced by anti-CD4 monoclonal antibody in the murine model. Transplantation 1993; 55: 361.
19. Cosimi AB, Conti D, Delmonico FL, et al. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J Immunol 1990; 144: 4604.
20. Hancock WW, Sayegh MH, Sablinski T, et al. Blocking of mononuclear cell accumulation, cytokine production, and endothelial activation within rat cardiac allografts by CD4 monoclonal antibody therapy. Transplantation 1992; 53: 1276.
21. Pearson TC, Bushell AR, Darby CR, West LJ, Morris PJ, Wood KJ. Lymphocyte changes associated with prolongation of cardiac allograft survival in adult mice using anti-CD4 monoclonal antibody. Clin Exp Immunol 1993; 92: 211.
22. Nakakura EK, McCabe SM, Zheng B, et al. Potent and effective prolongation by anti-LFA-1 monoclonal antibody monotherapy of non-primarily vascularized heart allograft survival in mice without T cell depletion. Transplantation 1993; 55: 412.
23. Waldmann H, Cobbold SP, Qin S, Benjamin RJ, Wise M. Tolerance induction in the adult using monoclonal antibodies to CD4, CD8, and CD11a (LFA-1). Cold Spring Harb Symp Quant Biol 1989; 54: 885.
24. Pearson TC, Alexander DZ, Winn K, Linsley P, Lowry R, Larsen C. Transplantation tolerance induced by CTLA4-Ig. Transplantation 1994; 57: 1701.
25. Linsley PS, Wallace PM, Johnson J, et al. Immunosuppression in vivo by a soluble form of the CTLA-4T cell activation molecule. Science 1992; 257: 792.
26. Baliga P, Chavin KD, Qin L, et al. CTLA4-Ig prolongs allograft survival while suppressing cell-mediated immunity. Transplantation 1994; 58: 1082.
27. Dansereau G, Tremblay JP, Belles-Isles M, Huard J, Labrecque C, Bouchard JP. Expression of major histocompatibility complex antigens on human myoblasts. Transplant Proc 1991; 23: 799.
28. Goebels N, Michealis D, Wekerle H, Hohlfeld R. Human myoblasts as antigen-presenting cells. J Immunol 1992; 140: 661.
29. Michealis D, Goebels N, Hohfield R. Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes. Am J Pathol 1993; 143: 1142.
30. Lin H, Wei RQ, Gordon D, Linsley P, Turka LA, Bolling SF. Review of CTLA4-Ig use for allograft immunosuppression. Transplant Proc 1994; 26: 3200.
31. Bushell A, Pearson TC, Morris PJ, Wood KJ. Donor-recipient microchimerism is not required for tolerance induction following recipient pretreatment with donor-specific transfusion and anti-CD4 antibody. Transplantation 1995; 59: 1367.